Safety Data Sheet

Supplier: Berdynaj Ramiz (Drakon Peptides), Franzosenhausweg 45, 4030 Linz, Austria. UID ATU79715747. Email: [email protected].

Emergency contact: [email protected] (Mon–Fri, 09:00–18:00 CET). For acute medical emergencies, contact your national poison information centre.

2.1 CLP Classification: Based on currently available data, the substance is not classified as hazardous under Regulation (EC) No 1272/2008 (CLP).

2.2 Label elements: No GHS pictograms, signal word, or hazard / precautionary statements are required by CLP for this substance at the available data level.

2.3 Other hazards: The substance does not meet PBT (persistent, bioaccumulative, toxic) or vPvB (very persistent, very bioaccumulative) criteria per REACH Annex XIII. No endocrine-disrupting properties identified at this time.

Synthetic 30-amino acid analogue of GHRH(1-29). NOT the DAC-modified variant.

Eye contact: Immediately rinse with running water for at least 15 minutes, holding eyelids open. Remove contact lenses if easily removable. If irritation persists, seek ophthalmological assessment.

Skin contact: Remove contaminated clothing. Wash affected skin thoroughly with soap and plenty of water. Seek medical advice if irritation develops.

Inhalation: Move the affected person to fresh air. If breathing is difficult, administer oxygen. Obtain medical assistance if symptoms persist.

Ingestion: Rinse mouth thoroughly with water. Do not induce vomiting. Never give anything by mouth to an unconscious person. Seek medical advice immediately.

Symptoms: No specific acute or delayed effects have been documented for laboratory-scale handling. Treat symptomatically.

Suitable extinguishing media: Dry chemical, alcohol-resistant foam, carbon dioxide (CO₂), or water spray.

Hazardous decomposition products: Combustion may release oxides of carbon (CO, CO₂), oxides of nitrogen (NOₓ), and other irritant or toxic fumes.

Protective equipment: Self-contained breathing apparatus (SCBA) with full-face mask and full chemical-resistant protective clothing.

Personal precautions: Avoid generation and inhalation of dust. Wear PPE specified in Section 8. Restrict access to the contaminated area until cleanup is complete.

Environmental precautions: Prevent the substance from entering drains, sewers, surface water, or soil.

Containment & cleanup: Carefully sweep or vacuum (HEPA-filtered) the spilled material. Place residues into a sealed, clearly labelled waste container. Decontaminate the affected surface with water. Dispose of waste in accordance with Section 13.

Safe handling: Handle exclusively in a properly ventilated laboratory environment. Avoid contact with skin and eyes; avoid generating dust or aerosols. Wash hands and exposed skin after handling. Do not eat, drink, or smoke in handling areas.

Storage: Keep the original container tightly sealed in a cool, dry, well-ventilated location, protected from light and moisture. Lyophilized form: long-term storage at −20 °C to −80 °C is recommended; short-term storage at 2–8 °C is acceptable. Reconstituted solution: store at 2–8 °C and use within the timeframe specified in batch documentation.

Specific end use(s): In vitro laboratory research and analytical applications only.

Occupational exposure limits: No EU-wide or national occupational exposure limit values have been established for this substance.

Engineering controls: Local exhaust ventilation or fume hood when handling powder, particularly during weighing or reconstitution.

Personal protective equipment:

• Eye protection: tight-fitting safety goggles compliant with EN 166.
• Skin protection: chemical-resistant nitrile gloves compliant with EN ISO 374-1; laboratory coat.
• Respiratory protection: particulate filter mask (FFP2 or FFP3 per EN 149) when adequate ventilation is not available.

Reactivity: No hazardous reactivity reported under recommended handling and storage conditions.

Chemical stability: Stable when stored as specified in Section 7.

Conditions to avoid: Elevated temperatures, direct sunlight, excessive humidity, repeated freeze-thaw cycles after reconstitution.

Incompatible materials: Strong oxidising agents, strong acids, strong alkalis.

Hazardous decomposition products: Under fire conditions: oxides of carbon and nitrogen.

No comprehensive toxicological data are available for this substance.

Product: Dispose of as laboratory waste through a licensed hazardous-waste contractor in accordance with Directive 2008/98/EC and applicable national or local regulations. Do not release into drains, surface water, or soil.

Contaminated packaging: Treat as hazardous waste unless thoroughly decontaminated. Recycle or dispose of according to local regulations.

This substance is not classified as a dangerous good for transport under any of the following frameworks:

Applicable EU legislation:

• Regulation (EC) No 1907/2006 (REACH), as amended.
• Regulation (EC) No 1272/2008 (CLP), as amended.
• Commission Regulation (EU) 2020/878 (revised SDS format).
• Directive 2008/98/EC (Waste Framework Directive).
• Directive 89/686/EEC and Regulation (EU) 2016/425 (PPE).

Austrian implementation: Bundesgesetz über den Schutz vor gefährlichen Stoffen (Chemikaliengesetz 1996, BGBl. Nr. 53/1997, as amended).

Chemical Safety Assessment: A CSA under REACH Title II Chapter 2 has not been performed; the substance is imported below the 1 t/y registration threshold (Art. 6) per Drakon Peptides REACH Self-Declaration.

Sources: Manufacturer Certificate of Analysis; ECHA C&L Inventory (echa.europa.eu); PubChem (pubchem.ncbi.nlm.nih.gov); Janoshik Analytical independent verification reports (janoshik.com).

Revision summary: Version 1.0 — Drakon Peptides, issued 6 June 2026. Initial issue under Drakon Peptides import operations.

Disclaimer: The information contained in this Safety Data Sheet has been compiled from sources believed to be reliable and is provided for guidance on safe handling, use, and disposal. This document does not constitute a guarantee of product properties under any specific use case. Drakon Peptides accepts no liability for any damage or injury arising from handling, storage, or use of this product outside its identified use as a laboratory reagent for in vitro research.

Cross-reference: See also Drakon Peptides REACH Self-Declaration at drakonpeptides.com/reach-declaration/